New insight into a complex plant–fungal pathogen interaction

2015 ◽  
Vol 47 (2) ◽  
pp. 101-103 ◽  
Author(s):  
Peter J Balint-Kurti ◽  
James B Holland
2020 ◽  
pp. 247-266
Author(s):  
Richa Kamboj ◽  
Manoj Nath ◽  
Bhavna Thakur ◽  
Tapan Kumar Mondal ◽  
Deepesh Bhatt ◽  
...  

2018 ◽  
Vol 11 (2) ◽  
pp. 235-244 ◽  
Author(s):  
Chenlei Hua ◽  
Jian-Hua Zhao ◽  
Hui-Shan Guo

2012 ◽  
Vol 21 (16) ◽  
pp. 3931-3946 ◽  
Author(s):  
C. DUTECH ◽  
B. BARRÈS ◽  
J. BRIDIER ◽  
C. ROBIN ◽  
M. G. MILGROOM ◽  
...  

2018 ◽  
Vol 19 (4) ◽  
pp. 303-309 ◽  
Author(s):  
Keevan J. MacKenzie ◽  
Leilani G. Sumabat ◽  
Katia V. Xavier ◽  
Gary E. Vallad

Corynespora cassiicola is a highly diverse fungal pathogen that can infect more than 500 species of plants, including many economically important crops such as cotton, soybean, tomato, and cucumber. In Florida, the number one vegetable crop by market value are fresh-market tomatoes, which generate nearly half a billion dollars annually. Florida’s subtropical to tropical climate is conducive to infection and development of the target spot pathogen on tomato caused by C. cassiicola. There is no varietal resistance available for target spot of tomato, and preventative fungicide treatments are the primary method for control. In the last decade, C. cassiicola has been more frequently reported by Florida tomato growers, appearing not only more aggressive but also increasingly insensitive to various fungicides. This review brings together the most recent C. cassiicola literature, providing a history and understanding of the immense pathogen diversity and its relevance to tomato. It also provides insight into fungicide resistance development and pathogen survivability, which are important factors in providing effective control recommendations and in understanding the epidemiology of this disease, respectively.


2021 ◽  
Author(s):  
Hiralal Sonawane ◽  
Swapnil Ghule ◽  
SK Math ◽  
Deepak B. Shelke ◽  
Ganesh NIkalje

2017 ◽  
Vol 62 (2) ◽  
Author(s):  
Jessica L. Chitty ◽  
Mark S. Butler ◽  
Azzah Suboh ◽  
David J. Edwards ◽  
Matthew A. Cooper ◽  
...  

ABSTRACTResistance to antimicrobials is a growing problem in both developed and developing countries. In nations where AIDS is most prevalent, the human fungal pathogenCryptococcus neoformansis a significant contributor to mortality, and its growing resistance to current antifungals is an ever-expanding threat. We investigated octapeptin C4, from the cationic cyclic lipopeptide class of antimicrobials, as a potential new antifungal. Octapeptin C4 was a potent, selective inhibitor of this fungal pathogen with an MIC of 1.56 μg/ml. Further testing of octapeptin C4 against 40 clinical isolates ofC. neoformansvar.grubiiorneoformansshowed an MIC of 1.56 to 3.13 μg/ml, while 20 clinical isolates ofC. neoformansvar.gattiihad an MIC of 0.78 to 12.5 μg/ml. In each case, the MIC values for octapeptin C4 were equivalent to, or better than, current antifungal drugs fluconazole and amphotericin B. The negatively charged polysaccharide capsule ofC. neoformansinfluences the pathogen's sensitivity to octapeptin C4, whereas the degree of melanization had little effect. Testing synthetic octapeptin C4 derivatives provided insight into the structure activity relationships, revealing that the lipophilic amino acid moieties are more important to the activity than the cationic diaminobutyric acid groups. Octapeptins have promising potential for development as anticryptococcal therapeutic agents.


2014 ◽  
Vol 41 (1) ◽  
pp. 1-9
Author(s):  
Jin Yeong Kim ◽  
So Eui Lee ◽  
Ha Ram Oh ◽  
In Soo Choi ◽  
Yong Chul Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document